» Articles » PMID: 21069585

The Effect of Telephone-administered Cognitive-behavioral Therapy on Quality of Life Among Patients with Multiple Sclerosis

Overview
Journal Ann Behav Med
Specialty Social Sciences
Date 2010 Nov 12
PMID 21069585
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Past research has found that a variety of physical, psychological, and social factors can affect quality of life (QOL). These previous findings suggest that interventions that address these factors could potentially improve QOL.

Purpose: The purpose of this study was to examine whether cognitive behavioral therapy (CBT) can improve QOL, and if so, explore which factors might mediate this effect.

Methods: This is a secondary analysis of a randomized controlled trial. One hundred twenty-seven participants with multiple sclerosis and depression were randomly assigned to either a telephone-administered CBT (T-CBT) or telephone-administered supportive emotion-focused therapy (T-SEFT) intervention.

Results: Patients assigned to T-CBT showed significantly greater improvements in QOL compared with those assigned to T-SEFT. The greater improvement in QOL among T-CBT recipients was mediated by improvements in depression and positive affect. There was also inconsistent support for the superior effect of CBT on QOL being mediated by improvement in fatigue.

Conclusions: T-CBT provided greater QOL benefits compared with T-SEFT, which controlled for non-specific treatment components. This study further suggests that T-CBT procedures specific to the management of depression and positive affect were uniquely useful in improving QOL.

Citing Articles

Evaluating the Efficacy of Telehealth-Based Treatments for Depression in Adults: A Rapid Review and Meta-Analysis.

Nowrouzi-Kia B, Bani-Fatemi A, Jackson T, Li A, Chattu V, Lytvyak E J Occup Rehabil. 2024; .

PMID: 39485666 DOI: 10.1007/s10926-024-10246-3.


[Telephone assistance for neurological diseases: a systematic review].

Trejo-Gabriel-Galan J, Cubo-Delgado E Rev Neurol. 2023; 77(3):67-73.

PMID: 37466132 PMC: 10662245. DOI: 10.33588/rn.7703.2022284.


Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.

Ioannides Z, Csurhes P, Douglas N, Mackenroth G, Swayne A, Thompson K Front Neurol. 2021; 12:652811.

PMID: 33790852 PMC: 8005645. DOI: 10.3389/fneur.2021.652811.


Effects of Teleassistance on the Quality of Life of People With Rare Neuromuscular Diseases According to Their Degree of Disability.

Martinez O, Amayra I, Lopez-Paz J, Lazaro E, Caballero P, Garcia I Front Psychol. 2021; 12:637413.

PMID: 33737897 PMC: 7960659. DOI: 10.3389/fpsyg.2021.637413.


Psychological Interventions for People with Huntington's Disease: A Call to Arms.

Zarotti N, Dale M, Eccles F, Simpson J J Huntingtons Dis. 2020; 9(3):231-243.

PMID: 32894248 PMC: 7683059. DOI: 10.3233/JHD-200418.


References
1.
Bol Y, Duits A, Hupperts R, Vlaeyen J, Verhey F . The psychology of fatigue in patients with multiple sclerosis: a review. J Psychosom Res. 2008; 66(1):3-11. DOI: 10.1016/j.jpsychores.2008.05.003. View

2.
Mohr D, Boudewyn A, Goodkin D, Bostrom A, Epstein L . Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol. 2002; 69(6):942-9. View

3.
Mohr D, Hart S, Goldberg A . Effects of treatment for depression on fatigue in multiple sclerosis. Psychosom Med. 2003; 65(4):542-7. DOI: 10.1097/01.psy.0000074757.11682.96. View

4.
Potts M, Daniels M, Burnam M, Wells K . A structured interview version of the Hamilton Depression Rating Scale: evidence of reliability and versatility of administration. J Psychiatr Res. 1990; 24(4):335-50. DOI: 10.1016/0022-3956(90)90005-b. View

5.
Mohr D, Genain C . Social support as a buffer in the relationship between treatment for depression and T-cell production of interferon gamma in patients with multiple sclerosis. J Psychosom Res. 2004; 57(2):155-8. DOI: 10.1016/S0022-3999(03)00601-9. View